NCT07206225 A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer Status RECRUITING Phase PHASE1
NCT07123090 A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT06974734 A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies Status TERMINATED Phase PHASE1
NCT06870487 A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers Status TERMINATED Phase PHASE1
NCT06580938 A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer Status TERMINATED Phase PHASE1
NCT06546553 A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines. Status TERMINATED Phase PHASE1
NCT06448364 A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination Status TERMINATED Phase PHASE1
NCT06285097 A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06218069 Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT05665361 Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) Status RECRUITING Phase PHASE1/PHASE2
NCT05259397 PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) Status WITHDRAWN Phase PHASE1
NCT05241340 Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05233436 PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT05061537 Study of PF-07263689 in Participants With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT04585815 Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) Status TERMINATED Phase PHASE1/PHASE2
NCT04458259 Study of PF-07265807 in Participants With Metastatic Solid Tumors. Status TERMINATED Phase PHASE1